The Hyperthyroid Cat Centre Ltd.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

The Hyperthyroid Cat Centre Ltd. - overview

Established

2013

Location

-, West Yorkshire, UK

Primary Industry

Healthcare Specialists

About

The Hyperthyroid Cat Centre Ltd. offers specialized medical treatment for feline hyperthyroidism, focusing on radio-iodine therapy, recognized for its effectiveness in restoring feline health efficiently and safely. Founded in 2013 in the UK, The Hyperthyroid Cat Centre Ltd. is dedicated to treating feline hyperthyroidism.


The company was acquired by VetPartners Limited in September 2020, although no details regarding the financial terms were disclosed. The founder's history and previous ventures are not specified. The Hyperthyroid Cat Centre specializes in comprehensive medical treatment for feline hyperthyroidism, primarily offering radio-iodine treatment, noted for its capacity to provide a permanent cure. Typically, cats can be discharged as early as four days post-treatment.


The Centre caters to a diverse client base, including cat owners and veterinary practices across the UK, ensuring tailored care for each feline patient. Additionally, it provides educational resources on hyperthyroidism, covering causes, symptoms, treatment, and prevention strategies. In the most recent financial year, 2024, The Hyperthyroid Cat Centre reported a revenue of USD 1. 07 bn and an EBITDA of USD 128.


78 mn, indicating a robust operational performance driven by its specialized treatment offerings. As of the latest update in September 2020, The Hyperthyroid Cat Centre plans to leverage its acquisition by VetPartners Limited to enhance its services and expand its market reach. Future growth strategies include the introduction of new treatment options and educational programs aimed at cat owners. Specific markets for expansion are currently unannounced, but the Centre aims to build upon its existing clientele while exploring potential new regions for service delivery.


Current Investors

VetPartners Limited

Primary Industry

Healthcare Specialists

Sub Industries

Healthcare Specialists

Website

www.hyperthyroidcatcentre.co.uk

Company Stage

Add-on

Total Amount Raised

Subscriber access only

The Hyperthyroid Cat Centre Ltd. - timeline of key events

Blurred Background

Want to see the Timeline of Key Events?

Request a demo for full access to this profile.

The Hyperthyroid Cat Centre Ltd. - financials

Fiscal Year EndedJun 30, 2021Jun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025
Revenue (USD)579,012922,853---
% Revenue Growth (YoY)-59.4%---
EBITDA (USD)53,587170,601---
Operating Income (USD)44,003154,842---
Operating Margin7.6%16.8%---
% EBITDA Margin9.3%18.5%---
NET Income (USD)55,841180,261---
% Net Margin9.6%19.5%---

The Hyperthyroid Cat Centre Ltd. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedThe Hyperthyroid Cat Centre Ltd.-

Displaying 1 - 1 of 1

The Hyperthyroid Cat Centre Ltd. - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.